Biokin Pharmaceutical selects Cryoport’s temperature-controlled solutions
Biokin Pharmaceutical Co. Ltd. has selected Cryoport’s full suite of temperature-controlled solutions to support its Phase I and II clinical trials in immuno-oncology in both the US and China.